Zoran Zdraveski is of TScan Therapeutics, Inc.. Currently has a direct ownership of 4,716 shares of TCRX, which is worth approximately $22,306. The most recent transaction as insider was on Aug 23, 2024, when has been sold 164,686 shares (Voting Common Stock) at a price of $5.78 per share, resulting in proceeds of $951,885. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.72K
0% 3M change
0% 12M change
Total Value Held $22,306

ZORAN ZDRAVESKI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2024
SELL
Open market or private sale
$951,885 $5.78 p/Share
164,686 Reduced 97.22%
4,716 Voting Common Stock
Aug 23 2024
BUY
Exercise of conversion of derivative security
$488,848 $3.11 p/Share
157,186 Added 48.13%
169,402 Voting Common Stock
Sep 23 2021
BUY
Open market or private purchase
$35,276 $7.48 p/Share
4,716 Added 50.0%
4,716 Voting Common Stock

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
ZZ

Zoran Zdraveski

Waltham, MA

Track Institutional and Insider Activities on TCRX

Follow TScan Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRX shares.

Notify only if

Insider Trading

Get notified when an T Scan Therapeutics, Inc. insider buys or sells TCRX shares.

Notify only if

News

Receive news related to TScan Therapeutics, Inc.

Track Activities on TCRX